Nanotherapeutigs for skin diseases

Nanotherapeutics: Drug Delivery Concepts in Nanoscience

Volumn , Issue , 2008, Pages 125-161

  Atrux tallau, Nicolas ^a   Falson, Françoise ^a   Pirot, Fabrice ^a,b  

^a Clinical and Therapeutic Aspects of the Skin Barrier Function   (France)

^b HÔPITAL DEBROUSSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80051802766     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4032/9789814241168     Document Type: Chapter

References (124)

1. Agache, P. (2004). The human skin: An overview. In: P. Agache and P. Humbert (Editors), Measuring the skin, Springer-Verlag, Berlin Heidelberg, pp. 3-5.
2. Agarwal, R., Katare, O. P. and Vyas, S. P. (2001). Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int. J. Pharm., 228, pp. 43-52.
3. Agarwal, R., Saraswat, A., Kaur, I., Katare, O. P. and Kumar, B. (2002). A novelliposomal formulation of dithranol for psoriasis: preliminary results. J. Dermatol., 29, pp. 529-32.
4. Alberti, I., Kalia, Y. N., Naik, A., Bonny, J. D. and Guy, R. H. (2001). In vivo assessment of enhanced topical delivery of terbinafine to human stratum corneum. J. Control. Rel., 71, pp. 319-327.
5. Alsarra, I. A., Bosela, A. A., Ahmed, S. M. and Mahrous, G. M. (2005). Proniosomes as a drug carrier for transdermal delivery of ketorolac. Eur. J. Pharm. Biopharm., 59, pp. 485-490.
6. Alvarez-Figueroa, M. J. and Blanco-Mendez, J. (2001). Transdermal delivery of methotrexate: iontophoretic delivery from hydrogels and passive delivery from microemulsions. Int. J. Pharm., 215, pp. 57-65.
7. Baroli, B., Lopez-Quintela, M. A., Delgado-Charro, M. B. and Fadda, A. M., Blanco-Mendez, J. (2000). Microemulsions for topical delivery of 8-methoxsalen. J. Control. ReI., 69, pp. 209-218.
8. Beetge, E., du Plessis, J., Muller, D. G., Goosen, C. and van Rensburg, F. J. (2000). The influence of the physico-chemical characteristics and pharmacokinetic properties of selected NSAID's on their transdermal absorption. Int. J. Pharm., 193, pp. 261-264.
9. Brinon, L., Geiger, S., Alard, V., Doucet, J., Tranchant, J.-F. and Couarraze, G. (1999). Percutaneous absorption of sunscreens from liquid crystalline phases. J. Control. Rel., 60, pp. 67-76.
10. Castelli, F., Puglia, C., Sarpietro, M. G., Rizza, L. and Bonina, F. (2005 a). Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry. Int. J. Pharm., 304, pp. 231-238.
11. Cevc, G. (2004). Lipid vesicles and other colloids as drug carriers on the skin. Adv. Drug Deliv. Rev., 56, pp. 675-711.
12. Cevc, G., Blume, G. and Schatzlein, A. (1997). Transfersomes-mediated transepidermal delivery improves the regio-specificity and biological activity of corticosteroids in vivo. J. Control. Rel., 45, pp. 211-226.
13. Cevc, G., Blume, G., Schatzlein, A., Gebauer, D. and Paul, A. (1996). The skin: a pathway for systemic treatment with patches and lipid-based agent carriers. Adv. Drug Deliv. Rev., 18, pp. 349-378.
14. Cevc, G. and Blume, G. (1992). Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim. Biophys. Acta, 1104, pp.226-232.
15. Cevc, G. and Gebauer, D. (2003). Hydration-driven transport of deformable lipid vesicles through fine pores and the skin barrier, Biophys. I., 84, pp. 1010-1024.
16. Cevc, G., Schatzlein, A. and Blume, G. (1995). Transdermal drug carriers: Basic properties, optimization and transfer efficiency in the case of epicutaneously applied peptides. J. Control. ReI., 36, pp. 3-16.
17. Cevc, G., Schatzlein, A. and Richardsen, H. (2002). Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements. Biochim. Biophys. Acta, 1564, pp. 21-30.
18. Chen, H., Chang, X., Du, D., Liu, W., Liu, J., Weng, T., Yang, Y., Xu, H. and Yang, X. (2006 b). Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J. Control. Rel., 110, pp. 296-306.
19. Chetoni, P., Rossi, S., Burgalassi, S., Monti, D., Mariotti, S. and Saettone, M. F. (2004). Comparison of Liposome-Encapsulated Acyclovir with Acyclovir Ointment: Ocular Pharmacokinetics in Rabbits. J. Ocular Pharmacol. Therap., 20, pp. 169-177.
20. Danielsson, I. and Lindman, B. (1981). The definition of microemulsion. Colloids and Surfaces, 3, pp. 391-392.
21. Date, A. A., Naik, B. and Nagarsenker, M. S. (2006). Novel drug delivery systems: Potential in improving topical delivery of anti acne agents. Skin Pharmacol. Physiol., 19, pp. 2-16.
22. Dayan, N. and Touitou, E. (2000). Carriers for skin delivery of trihexyphenidyl HCI: ethosomes vs.liposomes. Biomaterials, 21(18), pp. 1879-1885.
23. de Rie, M. A., Goedkoop, A. Y. and Bos, J. D. (2004). Overview of psoriasis. Dermatol. Ther., 17(5), pp. 341-349.
24. Degim, I. T. (2006). New tools and approaches for predicting skin permeability. Drug Discovery Today, 11(11-12), pp. 517-523.
25. Delneuville, I., Dechesne, J. P. and Del attre, L. (1998). Preparation and study of the characteristics of dithranol:polyvinylpyrrolidone coevaporates, Int. J. Pharm., 168, pp. 109-118.
26. Dubey, V., Mishra, D., Jain, N. K. (2007). Melatonin loaded ethanolic liposomes: Physicochemical characterization and enhanced transdermal delivery, Eur. J. Pharm. Biopharm., in press.
27. Elsayed, M. M. A., Abdallah, O. Y., Naggar, V. F. and Khalafallah, N. M. (2007). Deformable liposomes and ethosomes: Mechanism of enhanced skin delivery. Int. J. Pharm., 322, pp. 60-66.
28. Elsayed, M. M. A., Abdallah, O. Y., Naggar, V. F. and Khalafallah, N. M. Lipid vesicles for skin delivery of drugs: Reviewing three decades of research. Int. J. Pharm., in press.
29. Elzainy, A. A., Gu, X., Simons, F. E. and Simons K. J. (2003). Hydroxyzine from topical phospholipid liposomal formulations: evaluation of peripheral antihistaminic activity and systemic absorption in a rabbit model. AAPS PharmSci, 5, pp. E28.
30. Esposito, E., Cortesi, R., Drechsler, M., Paccamiccio, L., Mariani, P., Contado, C., Stellin, E., Menegatti, E., Bonina, F. and Puglia, C. (2005). Cubosome dispersions as delivery systems for percutaneous administration of indomethacin, Pharm. Res., 22, pp. 2163-2173.
31. Fang, J.-Y., Hong, C.-T., Chiu, W.-T. and Wang, Y.-Y. (200Ia). Effect ofliposomes and niosomes on skin permeation of enoxacin. Int. J. Pharm., 219, pp. 61-72.
32. Fesq, H., Lehmann, J., Kontny, A., Erdmann, I., Theiling, K., Rother, M., Ring, I., Cevc, G. and Abeck, D. (2003). Improved risk-benefit ratio for topical triamcinolone acetonide in Transfersome in comparison with equipotent cream and ointment: a randomized controlled trial. Br. J. Dermatol., 149, pp. 611-619.
33. Fluhr, J. W., Barsom, 0., Gehring, W. and Gloor, M. (1999). Antibacterial efficacy of benzoyl peroxide in phospholipid liposomes. A vehicle-controlled, comparative study in patients with papulopustular acne. Dermatology, 198, pp. 273-277.
34. Fogh, K. and Kragballe, K. (2004). New vitamin D analogs in psoriasis, Curro Drug Targets Inflamm. Allergy, 3, pp. 199-204.
35. Foldvari, M., Gesztes, A. and Mezei, M. (1990). Dermal drug delivery by liposome encapsulation: clinical and electron microscopic studies, J. Microencaps., 7, pp.479-489.
36. Fresno Contreras, M. J., Jimenez Soriano, M. M. and Ramirez Dieguez, A. (2005). In vitro percutaneous absorption of all-trans retinoic acid applied in free form or encapsulated in stratum corneum lipid liposomes. Int. J. Pharm., 297, pp. 134-145.
37. Fresta, M. and Puglisi, G. (1996). Application of liposomes as potential cutaneous drug delivery systems. In vitro and in vivo investigation with radioactively labelled vesicles. J. Drug Target., 4(2), pp. 95-101.
38. Fresta, M. and Puglisi, G. (1997). Corticosteroid dermal delivery with skin-lipid liposomes.l. Control. ReI., 44, pp. 141-151.
39. Geinoz, S., Guy, R. H., Testa, B. and Carrupt, P.-A. (2004). Quantitative structure-permeation relationships (QSPeRs) to predict skin permeation: a critical evaluation. Pharm. Res., 21, pp. 83-92.
40. Godin, B. and Touitou, E. (2004). Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier. J. Control. ReI., 94(2-3), pp. 365-379.
41. Gomes, A. J., Faustino, A. S., Lunardi, C. N., Lunardi, L. O. and Machado, A. E. H. (2007). Evaluation of nanoparticles loaded with benzopsoralen in rat peritoneal exudate cells. Int. J. Pharm., 332, 153-160.
42. Gopinath, D., Ravi, D., Rao, B. R., Apte, S. S., Renuka, D. and Rambhau, D. (2004). Ascorbyl palmitate vesicles (Aspasomes): formation, characterization and applications. Int. J. Pharm., 271, pp. 95-113.
43. Gruber, D. M., Sator, M.O., Joura, E. A., Kokoschka, E. M., Heinze, G., Huber, J. C. (1998). Topical cyproterone acetate treatment in women with acne: a placebocontrolled tIial. Arch. Dermatol., 134, pp. 459-463.
44. Hadgraft, J. (2004). Skin deep. Eur. J. Pharm. Biopharm., 58, pp. 291-299.
45. Heurtault, B., Saulnier, P., Pech, B., Proust, J.-E. and Benoit, J.-P. (2003). Physico-chemical stability of colloidal lipid particles. Biomaterials, 24, pp. 4283-4300.
46. Hill, J. R., Wertz, P. W. (2003). Molecular models of the intercellular lipid lamellae from epidermal stratum corneum. Biochim. Biophys. Acta, 1616, pp. 121-126.
47. Hiruta, Y., Hattori, Y., Kawano, K, Obata, Y. and Maitani, Y. (2006). Novel ultradeformable vesicles entrapped with bleomycin and enhanced to penetrate rat skin. J. Control. Rel., 113, pp. 146-154.
48. Honzak, L. and Sentjurc, M. (2000). Development of liposome encapsulated clindamycin for treatment of acne vulgaris. Pflugers Arch., 440(5 Suppl), pp. R44-45.
49. Horwitz, E., Pisanty, S., Czerninski, R., Helser, M., Eliav, E. and Touitou, E. (1999). A clinical evaluation of a novel liposomal carrier for acyclovir in the topical treatment of recurrent herpes labialis. Oral Surg. Oral Med. Oral Pathol. Oral Radial. Endod., 87, pp. 700-705.
50. Hou, D., Xie, C., Huang, K and Zhu, C. (2003). The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials, 24, pp. 1781-1785.
51. Hu, F. Q., Jiang, S. P., Du, Y. Z., Yuan, H., Ye, Y. Q. and Zeng, S. (2006). Preparation and characteristics of monostearin nanostructured lipid carriers. Int. J. Pharm., 314, pp. 83-89.
52. Hu, F.-Q., Jiang, S.-P., Du, Y.-Z., Yuan, H., Ye, Y.-Q. and Zeng, S. (2005). Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids and Suifaces B: Biointeifaces, 45, pp. 167-173.
53. Iraji, F., Momeni, A., Naji, S. M. and Siadat, A. H. (2006). The efficacy of topical cyproterone acetate alcohol lotion versus placebo in the treatment of the mild to moderate acne vulgaris: a double blind study. Dermatol. Online J., 12, pp. 26.
54. Jenning, V., Gysler, A., Schafer-Korting, M. and Gohla, S. H. (2000a). Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin, Eur. J. Pharm. Biopharm., 49, pp. 211-218.
55. Jenning, V., Schafer-Korting, M. and Gohla, S. (2000b). Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties. J. Control. Rel., 66, pp. 115-126.
56. Jores, K., Mehnert, W., Drechsler, M., Bunjes, H., Johann, C. and Mader, K (2004). Investigations on the structure of solid lipid nanoparticles and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. J. Control. Rel., 95, pp. 217-227.
57. Kalia, Y. N., Alberti, I., Naik, A. and Guy, R. H. (2001). Assessment of topical bioavailability in vivo: the importance of stratum corneum thickness, Skin Pharmacol. Appl. Skin Physiol., 14, pp. 82-86.
58. Karzel, K. and Liedtke, R. K. (1989). Mechanisms of transcutaneous absorption. Pharmacologic and biochemical aspects. Arzneimittel-Forschung, 39, pp. 1487-1491.
59. Kemken, J., Ziegler, A. and Muller, B. W. (1992). Influence of supersaturation on the pharmacodynamic effect of bupranolol after dermal administration using microemulsions as vehicle. Pharm. Res., 9, pp. 554-8.
60. Kitagawa, S. and Kasamaki, M. (2006). Enhanced delivery of retinoic acid to skin by cationic liposomes. Chem. Pharm. Bull., 54, pp. 242-244.
61. Kogan, A. and Garti, N. (2006). Microemulsions as transdermal drug delivery vehicles. Adv. Colloid Interface Sci., 123-126, pp. 369-385.
62. Korbel, J. N., Sebok, B., Kerenyi, M. and Mahrle, G. (2001). Enhancement of the anti parakeratotic potency of calcitriol and tacalcitol in liposomal preparations in the mouse tail test. Skin Pharmacol. Appl. Skin Physiol., 14, pp. 291-5.
63. Korting, H. C., Zienicke, H., Schafer-Korting, M. and Braun-Falco, O. (1990). Liposome encapsulation improves efficacy of betamethasone dipropionate in atopic eczema but not in psoriasis vulgaris. Eur. J. Clin. Pharmacol., 39, pp. 349-351.
64. Kreilgaard, M. (2002). Influence of microemulsions on cutaneous drug delivery. Adv. Drug Deliv. Rev., 54, pp. S77-98.
65. Lademann, J., Richter, H., Teichmann, A., Otberg, N., Blume-Peytavi, U., Luengo, J., Weiss, B., Schaefer, U. F., Lehr, C.-M., Wepf, R. and Sterry, W. (2007). Nanoparticles - An efficient carrier for drug delivery into the hair follicles. Eur. J. Pharm. Biopharm., 66:159-164.
66. Law, S. L., Huang, K. J. and Chiang, C. H. (2000). Acyclovir-containing liposomes for potential ocular delivery. Corneal penetration and absorption. J Control. Rel., 63, pp.135-140.
67. Lboutounne, H., Faivre, V., Falson, F. and Pirot, F. (2004 a). Characterization of transport of chlorhexidine-Ioaded nanocapsules through hairless and Wi star rat skin. Skin Pharmacol. Appl. Skin Physiol., 17, pp. 176-182.
68. Lboutounne, H., Guillaume, Y. C., Michel, L., Makki, S., Humbert, P. and Millet, J. (2004 b). Study and Development of Encapsulated Forms of 4,5',8- Trimethylpsoralen for Topical Drug Delivery, Drug Dev. Res., 61, pp. 86-94.
69. Lebwohl, M., Ting, P. T. and Koo, J. Y. (2005). Psoriasis treatment: traditional therapy, Ann. Rheum. Dis., 64 Suppl 2, pp. 83-86.
70. Liu, J., Hu, W., Chen, H., Ni, Q., Xu, H. and Yang, X. (2007). Isotretinoin-Ioaded solid lipid nanoparticles with skin targeting for topical delivery. Int. J. Pharm., 328, pp.191-195.
71. Lodzki, M., Godin, B., Rakou, L., Mechoulam, R., Gallily, R. and Touitou, E. (2003). Cannabidiol--transdermal delivery and anti-inflammatory effect in a murine model. J. Control. Rel., 93, pp. 377-387.
72. Luengo, J., Weiss, B., Schneider, M., Ehlers, A., Stracke, F., Konig, K., Kostka, K. H., Lehr, C. M. and Schaefer, U. F. (2006). Influence of nanoencapsulation on human skin transport offlufenamic acid. Skin Pharmacol. Physiol., 19, pp. 190-7.
73. Maia, C. S., Mehnert, W. and Schafer-Korting, M. (2000). Solid lipid nanoparticles as drug carriers for topical glucocorticoids. Int. J. Pharm., 196, pp. 165-167.
74. Maia, C. S., Mehnert, W., Schaller, M., Korting, H. C., Gysler, A., Haberland, A. and Schiifer-Korting, M. (2002). Drug targeting by solid lipid nanoparticles for dermal use. J. Drug Target., 10, pp. 489-495.
75. Manconi, M., Sinico, c., Valenti, D., Lai, F. and Fadda, A. M. (2006). Niosomes as carriers for tretinoin: III. A study into the in vitro cutaneous delivery of vesicleincorporated tretinoin. Int. J. Pharm., 311, pp. 11-19.
76. Manconi, M., Sinico, C., Valenti, D., Loy, G. and Fadda, A. M. (2002). Niosomes as carriers for tretinoin. I. Preparation and properties. Int. J. Pharm., 234, pp.237-248.
77. Manconi, M., Valenti, D., Sinico, C., Lai, F., Loy, G., and Fadda, A. M. (2003). Niosomes as carriers for tretinoin. II. Influence of vesicular incorporation on tretinoin photostability. Int. J. Pharm., 260, pp. 261-72.
78. Mehnert, W. and Mader, K. (2001). Solid lipid nanoparticles: Production, characterization and applications. Adv. Drug Deliv. Rev., 47, pp. 165-196.
79. Meidan, V. M., Bonner, M. C. and Michniak, B. B. (2005). Transfollicular drug delivery - Is it a reality? Int. J. Pharm., 306, pp. 1-14.
80. Merz, K. and Sternberg, B. (1994). Incorporation of vitamin D3-derivatives in liposomes of different lipid types. J. Drug Target., 2, pp. 411-7.
81. Moghimi, H. R., Williams, A. C. and Barry, B. W. (1996). A lamellar matrix model for stratum corneum intercellular lipids. II. Effect of geometry of the stratum corneum on permeation of model drugs 5-fluorouracil and oestradiol. Int. J. Pharm., 131, pp. 117-129.
82. MUller, R. H., Mader, K. and Gohla, S. (2000). Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur. J. Pharm. Biopharm., 50, pp. 161-177.
83. Mura, S., Pirot, F., Manconi, M., FaIson, F. and Fadda, A. M. (2007). Liposomes and niosomes as potential carriers for dermal delivery of minoxidil. J. Drug Target., IS, pp. 101-108.
84. Norlen, L., Nicander, I., Lundh Rozell, B., Ollmar, S. and Forslind, B. (1999). Inter- and intra-individual differences in human stratum corneum lipid content related to physical parameters of skin barrier function in vivo. J. Invest. Dermatol., 112, pp.72-77.
85. Paolino, D., Lucania, G., Mardente, D., Alhaique, F. and Fresta, M. (2005). Ethosomes for skin delivery of ammonium glycyrrhizinate: In vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J. Control. Rel., 106, pp. 99-110.
86. Patel, V. B., Misra, A. and Marfatia, Y. S. (2000). Topicalliposomal gel of tretinoin for the treatment of acne: research and clinical implications. Pharm. Dev. Technol., 5, pp.455-64.
87. Patel, V. B., Misra, A. and Marfatia, Y. S. (200la). Clinical assessment of the combination therapy with liposomal gels of tretinoin and benzoyl peroxide in acne. AAPS PharmSciTech, 2, pp. E-TN4.
88. Patel, V. B., Misra, A. N. and Marfatia, Y. S. (200Ib). Preparation and comparative clinical evaluation of liposomal gel of benzoyl peroxide for acne. Drug Dev. Ind. Pharm., 27(8), pp. 863-869.
89. Pathak, M. A. and Fitzpatrick, T. B. (1992). The evolution of photochemotherapy with psoralens and DVA (PDVA): 2000 BC to 1992 AD. J. Photochem. Photobiol. B., 14(1-2), pp. 3-22.
90. Pavelic, Z., Skalko-Basnet, N., Filipovic-Grcic, J., Martinac, A. and Jalsenjak, I. (2005). Development and in vitro evaluation of a liposomal vaginal delivery system for acyclovir. J. Control. ReI., 106, pp. 34-43.
91. Pirot, F., Berardesca, E., Kalia, Y. N., Singh, M., Maibach, H. I. and Guy, R. H. (1998). Stratum corneum thickness and apparent water diffusivity: facile and noninvasive quantitation in vivo, Pharm. Res., 15, pp. 492-494.
92. Pirot, F. and Falson, F. (2004). Skin barrier function. In: P. Agache and P. Humbert (Editors), Measuring the skin (Springer-Verlag, Berlin Heidelberg), pp. 513-524.
93. Potapenko, A. Y. and Kyagova, A. A. (1998). The application of antioxidants in investigations and optimization of photochemotherapy. Membr. Cell BioI., 12, pp. 269-278.
94. Prufer, K. and Jirikowski, G. F. (1996). Liposomal incorporation changes the effect of 1.25-dihydroxyvitamin D3 on the phospholipase C signal transduction pathway and the eicosanoid cascade on keratinocytes in vitro. Biochem. Pharmacol., 51, pp.247-252.
95. Rao, G. D., Murthy, R. S. R., Marfaita, Y. S. and Shankar, R. (1994). Influence of liposomal drug entrapment on the performance of corticosteroid creams. Indian J. Dermatol., 60, pp. 5-7.
96. Rolland, A., (1993). Particulate carriers in dermal and transdermal delivery: myth or reality? In: A. Rolland (Editor), Pharmaceutical particulate carriers: therapeutic applications (Marcel Dekker, New York), pp. 367-42E
97. Saraswat, A., Agarwal, R., Kaur, I., Katare, O. P. and Kumar, B. (2002). Fabric-staining properties and washability of a novel liposomal dithranol formulation. J. Dermatolog. Treat., 13, pp. 119-122.
98. Saupe, A., Gordon, K. C. and Rades, T. (2006). Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryofield emission scanning electron microscopy and Raman spectroscopy. Int. J. Pharm., 314, pp. 56-62.
99. Schafer-Korting, M., Korting, H. C. and Ponce-Poschl, E. (1994). Liposomal tretinoin for uncomplicated acne vulgaris. Clin. Investig., 72, pp. 1086-1091.
100. Shalita, A. R. (2004). Acne: Clinical presentations. Clinics in Dermatology, 22, pp. 385-386.
101. Simeonova, M., Velichkova, R., Ivanova, G., Enchev, V. and Abrahams, I. (2003). Poly(butylcyanoacrylate) nanoparticles for topical delivery of 5-fluorouracil. Int. J. Pharm., 263, pp. 133-140.
102. Sinico, C., Manconi, M., Peppi, M., Lai, F., Valenti, D. and Fadda, A M. (2005). Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle-skin interaction. J. Control. Rel., 103, pp. 123-136.
103. Skalko, N., Cajkovac, M. and Jalsenjak, I. (1992). Liposomes with clindamycin hydrochloride in the therapy of acne vulgaris, Int. J. Pharm., 85, pp. 97-101.
104. Souto, E. B., Wissing, S. A, Barbosa, C. M. and Muller, R. H. (2004). Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int. J. Pharm., 278, pp. 71-77.
105. Stecova, J., Mehnert, W., Blaschke, T., Kleuser, B., Sivaramakrishnan, R., Zouboulis, C. C., Seltmann, H., Korting, H. C., Kramer, K. D. and Schafer-Korting, M. (2007). Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: particle characterisation and skin uptake. Pharm. Res., 24, pp. 991-1000.
106. Stinchcomb, A L., Pirot, F., Touraille, G. D., Bunge, A L. and Guy, R. H. (1999). Chemical uptake into human stratum corneum in vivo from volatile and nonvolatile solvents. Pharm. Res., 16(8), pp. 1288-1293.
107. Surber, C. and Smith, E. W. (2005). The mystical effects of dermatological vehicles. Dermatology, 210(2), pp. 157-168.
108. Tabbakhian, M., Tavakoli, N., Jaafari, M. R. and Daneshamouz, S. (2006). Enhancement of follicular delivery of finasteride by liposomes and niosomes: 1. In vitro permeation and in vivo deposition studies using hamster flank and ear models. Int. J. Pharm., 323, pp. 1-10.
109. Touitou, E., Dayan, N., Bergelson, L., Godin, B. and Eliaz, M. (2000). Ethosomes -novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J. Control. Rel., 65, pp. 403-418.
110. Touitou, E., Godin, B., Dayan, N., Weiss, C., Piliponsky, A. and Levi-Schaffer, F. (2001). Intracellular delivery mediated by an ethosomal carrier. Biomaterials, 22, pp. 3053-3059.
111. Trotta, M., Peira, E., Carlotti, M. E., and Gallarate, M. (2004). Deformable liposomes for dermal administration of methotrexate. Int. J. Pharm., 270, pp. 119-25.
112. Trotta, M., Ugazio, E., Peira, E. and Pulitano, C. (2003). Influence of ion pairing on topical delivery of retinoic acid from microemulsions. J. Control. Rel., 86, pp. 315-321.
113. Tschan, T., Steffen, H. and Supersaxo, A (1997). Sebaceous-gland deposition of isotretinoin after topical application: an in vitro study using human facial skin. Skin Pharmacol., 10, pp. 126-34.
114. van De Kerkhof, P. C. (2001). New developments in the treatment of psoriasis. Skin Pharmacol. Appl. Skin Physiol., 14, pp. 129-35.
115. Verma, D. D. and Fahr, A (2004). Synergistic penetration enhancement effect of ethanol and phospholipids on the topical delivery of cyclosporin A. J. Control. ReI., 97, pp.55-66.
116. Verma, D. D., Verma, S., Blume, G. and Fahr, A. (2003). Particle size of liposomes influences dermal delivery of substances into skin. Int. J. Pharm., 258, pp. 141-151.
117. Vogt, A, Combadiere, B., Hadam, S., Stieler, K M., Lademann, J., Schaefer, H., Autran, B., Sterry, W. and Blume-Peytavi, U. (2006). 40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CDla+ cells after transcutaneous application on human skin. J. Invest. Dermatol., 126, pp. 1316-1322.
118. Vora, B., Khopade, A J. and Jain, N. K (1998). Proniosome based transdermal delivery oflevonorgestrel for effective contraception. J. Control. ReI., 54, pp. 149-165.
119. Weyenberg, W., Filev, P., Van den Plas, D., Vandervoort, J., De Smet, K, Sollie, P. and Ludwig, A. (2007). Cytotoxicity of submicron emulsions and solid lipid nanopartic1es for dermal application. Int. J. Pharm., 337, pp. 291-298.
120. Wissing, S. A and Muller, R. H. (2002a). The influence of the crystallinity of lipid nanoparticles on their occlusive properties. Int. J. Pharm., 242, pp. 377-379.
121. Wissing, S. A and Muller, R. H. (2002 b). Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration. J. Control. ReI., 81, pp.225-233.
122. Wissing, S. A and Muller, R. H. (2003). Cosmetic applications for solid lipid nanoparticles (SLN). Int. J. Pharm., 254, pp. 65-68.
123. Wong, T. W., Zhao, Y. L., Sen, A., Hui, S. W. (2005). Pilot study of topical delivery of methotrexate by electroporation. Br. J. Dermatol., 152(3), pp. 524-530.
124. Yamaguchi, Y., Nagasawa, T., Nakamura, N., Takenaga, M., Mizoguchi, M., Kawai, S.I., Mizushima, Y. and Igarashi, R. (2005). Successful treatment of photo-damaged skin of nano-scale atRA particles using a novel transdermal delivery. J. Control. ReI., 104, pp. 29-40.